BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19582367)

  • 21. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
    Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
    J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.
    Kazakov DV; Sima R; Vanecek T; Kutzner H; Palmedo G; Kacerovska D; Grossmann P; Michal M
    Am J Dermatopathol; 2009 May; 31(3):248-55. PubMed ID: 19384065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Wnt-signaling pathway is not implicated in tumorigenesis of Merkel cell carcinoma.
    Liu S; Daa T; Kashima K; Kondoh Y; Yokoyama S
    J Cutan Pathol; 2007 Jan; 34(1):22-6. PubMed ID: 17214850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-catenin gene analysis in oral squamous cell carcinoma.
    Lo Muzio L; Goteri G; Capretti R; Rubini C; Vinella A; Fumarulo R; Bianchi F; Mastrangelo F; Porfiri E; Mariggiò MA
    Int J Immunopathol Pharmacol; 2005; 18(3 Suppl):33-8. PubMed ID: 16848985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APC and CTNNB1 mutations are rare in sporadic ependymomas.
    Onilude OE; Lusher ME; Lindsey JC; Pearson AD; Ellison DW; Clifford SC
    Cancer Genet Cytogenet; 2006 Jul; 168(2):158-61. PubMed ID: 16843107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene.
    Ganesan K; Ivanova T; Wu Y; Rajasegaran V; Wu J; Lee MH; Yu K; Rha SY; Chung HC; Ylstra B; Meijer G; Lian KO; Grabsch H; Tan P
    Cancer Res; 2008 Jun; 68(11):4277-86. PubMed ID: 18519687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
    Mueller W; Lass U; Wellmann S; Kunitz F; von Deimling A
    Acta Neuropathol; 2005 Mar; 109(3):314-20. PubMed ID: 15668788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.
    Cetani F; Pardi E; Banti C; Collecchi P; Viacava P; Borsari S; Fanelli G; Naccarato AG; Saponaro F; Berti P; Miccoli P; Pinchera A; Marcocci C
    Endocr Relat Cancer; 2010 Mar; 17(1):1-6. PubMed ID: 19755524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression and splicing isoform analysis of human Tcf-4 transcription factor in brain tumors.
    Howng SL; Huang FH; Hwang SL; Lieu AS; Sy WD; Wang C; Hong YR
    Int J Oncol; 2004 Dec; 25(6):1685-92. PubMed ID: 15547706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
    Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
    Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.
    Zirn B; Wittmann S; Graf N; Gessler M
    Cancer Lett; 2005 Mar; 220(1):115-20. PubMed ID: 15737694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin.
    Abdel-Rahman WM; Kalinina J; Shoman S; Eissa S; Ollikainen M; Elomaa O; Eliseenkova AV; Bützow R; Mohammadi M; Peltomäki P
    Hum Mutat; 2008 Mar; 29(3):390-7. PubMed ID: 18165946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and mutation analysis of EGFR, c-KIT, and β-catenin in pulmonary blastoma.
    Macher-Goeppinger S; Penzel R; Roth W; Dienemann H; Thomas M; Schnabel PA; Schirmacher P; Bläker H
    J Clin Pathol; 2011 Apr; 64(4):349-53. PubMed ID: 21292787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seminiferous tubule degeneration and infertility in mice with sustained activation of WNT/CTNNB1 signaling in sertoli cells.
    Boyer A; Hermo L; Paquet M; Robaire B; Boerboom D
    Biol Reprod; 2008 Sep; 79(3):475-85. PubMed ID: 18480464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
    Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
    Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
    Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKR1C2 small interfering RNA (siRNA) inhibited beta-catenin expression and transcriptional activation in human liver cancer cell line QGY7701.
    Lu DD
    Hepatogastroenterology; 2007; 54(79):2088-91. PubMed ID: 18251165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma.
    Schmidt A; Braeuning A; Ruck P; Seitz G; Armeanu-Ebinger S; Fuchs J; Warmann SW; Schwarz M
    Toxicology; 2011 Mar; 281(1-3):7-14. PubMed ID: 21237236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.